Healthcare provider profile · identity verified

Gary Jasbeck, M.D.

Family Practice · MILAN, MI · NPI 1356353353

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	417	120
Amlodipine Besylate	Amlodipine Besylate	344	96
Lisinopril	Lisinopril	314	90
Levothyroxine Sodium	Levothyroxine Sodium	263	66
Metformin Hcl	Metformin Hcl	179	50
Omeprazole	Omeprazole	164	45
Pravastatin Sodium	Pravastatin Sodium	159	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	153	43
Rosuvastatin Calcium	Rosuvastatin Calcium	143	43
Trazodone Hcl	Trazodone Hcl	134	37
Eliquis	Apixaban	122	31
Metoprolol Succinate	Metoprolol Succinate	122	38
Losartan Potassium	Losartan Potassium	120	31
Simvastatin	Simvastatin	112	31
Jardiance	Empagliflozin	108	24
Escitalopram Oxalate	Escitalopram Oxalate	97	28
Tamsulosin Hcl	Tamsulosin Hcl	92	29
Gabapentin	Gabapentin	82	27
Albuterol Sulfate Hfa	Albuterol Sulfate	79	33
Glipizide	Glipizide	78	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	22
Furosemide	Furosemide	77	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	17
Hydrochlorothiazide	Hydrochlorothiazide	74	24
Metoprolol Tartrate	Metoprolol Tartrate	73	21
Metformin Hcl Er	Metformin Hcl	72	19
Pantoprazole Sodium	Pantoprazole Sodium	69	19
Carvedilol	Carvedilol	68	18
Ezetimibe	Ezetimibe	61	16
Fluticasone Propionate	Fluticasone Propionate	61	21
Sertraline Hcl	Sertraline Hcl	57	14
Atenolol	Atenolol	54	12
Venlafaxine Hcl Er	Venlafaxine Hcl	54	suppressed
Trulicity	Dulaglutide	53	suppressed
Spironolactone	Spironolactone	51	12
Lovastatin	Lovastatin	48	13
Tramadol Hcl	Tramadol Hcl	45	15
Alprazolam	Alprazolam	44	12
Potassium Chloride	Potassium Chloride	43	11
Famotidine	Famotidine	42	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Donepezil Hcl	Donepezil Hcl	40	11
Meloxicam	Meloxicam	40	15
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Meclizine Hcl	Meclizine Hcl	24	13
Prednisone	Prednisone	24	18
Chlorthalidone	Chlorthalidone	22	suppressed
Ibuprofen	Ibuprofen	22	12
Pen Needle	Pen Needle, Diabetic	21	suppressed
Allopurinol	Allopurinol	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Latanoprost	Latanoprost	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Novolog Flexpen	Insulin Aspart	15	suppressed
Ozempic	Semaglutide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Mounjaro	Tirzepatide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error